Eslam B. Elkaeed

6.5k total citations · 1 hit paper
254 papers, 5.3k citations indexed

About

Eslam B. Elkaeed is a scholar working on Organic Chemistry, Molecular Biology and Computational Theory and Mathematics. According to data from OpenAlex, Eslam B. Elkaeed has authored 254 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 115 papers in Organic Chemistry, 103 papers in Molecular Biology and 44 papers in Computational Theory and Mathematics. Recurrent topics in Eslam B. Elkaeed's work include Synthesis and biological activity (80 papers), Computational Drug Discovery Methods (44 papers) and Bioactive Compounds and Antitumor Agents (31 papers). Eslam B. Elkaeed is often cited by papers focused on Synthesis and biological activity (80 papers), Computational Drug Discovery Methods (44 papers) and Bioactive Compounds and Antitumor Agents (31 papers). Eslam B. Elkaeed collaborates with scholars based in Saudi Arabia, Egypt and Pakistan. Eslam B. Elkaeed's co-authors include Ibrahim H. Eissa, Ahmed M. Metwaly, Hazem Elkady, Wagdy M. Eldehna, Aisha A. Alsfouk, Ibrahim M. Ibrahim, Ahmed A. Al‐Karmalawy, Bshra A. Alsfouk, Mohammed S. Taghour and Dalal Z. Husein and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Eslam B. Elkaeed

243 papers receiving 5.3k citations

Hit Papers

Molecular Docking and Dynamics Simulation Revealed the Po... 2021 2026 2022 2024 2021 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Molecular Docking and Dynamics Simulation Revealed the Potential Inhibitory Activity of ACEIs Against SARS-CoV-2 Targeting the hACE2 Receptor
    2021 209 citations Mohammed A. Dahab, Ahmed M. Metwaly et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eslam B. Elkaeed Saudi Arabia 38 2.7k 2.1k 887 674 560 254 5.3k
Kanchugarakoppal S. Rangappa India 52 5.4k 2.0× 3.5k 1.6× 306 0.3× 1.2k 1.8× 334 0.6× 472 9.6k
Mohammad Shahar Yar India 41 4.5k 1.7× 2.0k 1.0× 544 0.6× 475 0.7× 249 0.4× 183 6.6k
Yousry A. Ammar Egypt 43 4.1k 1.5× 1.3k 0.6× 314 0.4× 480 0.7× 275 0.5× 217 5.2k
Ähmed Kamal India 54 8.5k 3.1× 4.4k 2.1× 491 0.6× 675 1.0× 538 1.0× 412 11.2k
Mohamed A. Al‐Omar Saudi Arabia 36 2.9k 1.1× 936 0.4× 255 0.3× 377 0.6× 161 0.3× 316 4.6k
Harun Patel India 41 3.2k 1.2× 1.9k 0.9× 931 1.0× 478 0.7× 305 0.5× 241 5.6k
Wei Lü China 37 1.3k 0.5× 2.2k 1.0× 134 0.2× 516 0.8× 220 0.4× 239 4.6k
Abdulrahman A. Almehizia Saudi Arabia 29 1.3k 0.5× 978 0.5× 227 0.3× 264 0.4× 147 0.3× 185 2.5k
Raj Kumar India 37 2.7k 1.0× 1.6k 0.7× 229 0.3× 354 0.5× 140 0.3× 121 4.5k
Subhash Padhyé India 58 3.9k 1.4× 3.9k 1.8× 306 0.3× 4.5k 6.7× 1.0k 1.8× 211 11.1k

Countries citing papers authored by Eslam B. Elkaeed

Since Specialization
Citations

This map shows the geographic impact of Eslam B. Elkaeed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eslam B. Elkaeed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eslam B. Elkaeed more than expected).

Fields of papers citing papers by Eslam B. Elkaeed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eslam B. Elkaeed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eslam B. Elkaeed. The network helps show where Eslam B. Elkaeed may publish in the future.

Co-authorship network of co-authors of Eslam B. Elkaeed

This figure shows the co-authorship network connecting the top 25 collaborators of Eslam B. Elkaeed. A scholar is included among the top collaborators of Eslam B. Elkaeed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eslam B. Elkaeed. Eslam B. Elkaeed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Elgammal, Walid E., Hazem Elkady, Reda G. Yousef, et al.. (2025). New nicotinamide–thiadiazol hybrids as VEGFR-2 inhibitors for breast cancer therapy: design, synthesis and in silico and in vitro evaluation. RSC Advances. 15(18). 14477–14498. 4 indexed citations
2.
El‐Moselhy, Tarek F., Eman A. El-Bastawissy, Rehab Mustafa Badi, et al.. (2024). Development of new thieno[2,3-d]pyrimidines as dual EGFR and STAT3 inhibitors endowed with anticancer and pro-apoptotic activities. Bioorganic Chemistry. 143. 107101–107101. 21 indexed citations
3.
Elkady, Hazem, Hazem A. Mahdy, Mohammed S. Taghour, et al.. (2024). New thiazolidine-2,4-diones as potential anticancer agents and apoptotic inducers targeting VEGFR-2 kinase: Design, synthesis, in silico and in vitro studies. Biochimica et Biophysica Acta (BBA) - General Subjects. 1868(6). 130599–130599. 13 indexed citations
4.
Eissa, Ibrahim H., Hazem Elkady, Walid E. Elgammal, et al.. (2024). Integrated in silico and in vitro discovery of a new anticancer thiadiazole analog targeting VEGFR-2. Journal of Molecular Structure. 1312. 138641–138641. 13 indexed citations
5.
Tawfik, Haytham O., Eman F. Khaleel, Rehab Mustafa Badi, et al.. (2024). Discovery of Novel Pyridazine-Tethered Sulfonamides as Carbonic Anhydrase II Inhibitors for the Management of Glaucoma. Journal of Medicinal Chemistry. 67(2). 1611–1623. 22 indexed citations
6.
Abdulla, Maha‐Hamadien, Zainab M. Elsayed, Moataz A. Shaldam, et al.. (2024). Unveiling the potential of isatin-grafted phenyl-1,2,3-triazole derivatives as dual VEGFR-2/STAT-3 inhibitors: Design, synthesis and biological assessments. Bioorganic Chemistry. 151. 107626–107626. 16 indexed citations
7.
Dahab, Mohammed A., Mohammed A. Dahab, Eslam B. Elkaeed, et al.. (2024). New Thieno[2,3-d]pyrimidines as Anticancer VEGFR-2 Inhibitors with Apoptosis Induction: Design, Synthesis, and Biological and In Silico Studies. Medicinal Chemistry. 20(9). 876–899. 2 indexed citations
8.
Elkady, Hazem, Mohammed S. Taghour, Mohammed A. Dahab, et al.. (2023). New thiazolidine-2,4-diones as effective anti-proliferative and anti-VEGFR-2 agents: Design, synthesis, in vitro, docking, MD simulations, DFT, ADMET, and toxicity studies. Computational Biology and Chemistry. 107. 107958–107958. 16 indexed citations
9.
Shaldam, Moataz A., Radwan El‐Haggar, Taghreed A. Majrashi, et al.. (2023). 2,4-Diaryl-pyrimido[1,2-a]benzimidazole derivatives as novel anticancer agents endowed with potent anti-leukemia activity: Synthesis, biological evaluation and kinase profiling. European Journal of Medicinal Chemistry. 258. 115610–115610. 19 indexed citations
10.
Aly, Shaza H., Ahmed M. Elissawy, Mahmoud A. El Hassab, et al.. (2023). Comparative metabolic study of the chloroform fraction of three Cystoseira species based on UPLC/ESI/MS analysis and biological activities. Journal of Enzyme Inhibition and Medicinal Chemistry. 39(1). 2292482–2292482. 17 indexed citations
11.
Fazal, Tanzeela, Shahid Iqbal, Azam Hayat, et al.. (2023). Escherichia coli-assisted synthesis of AgFeO2 nanoparticles for antimicrobial, photocatalytic and hydrogen generation applications. Materials Chemistry and Physics. 312. 128680–128680. 3 indexed citations
12.
Eissa, Noura G., Wagdy M. Eldehna, Mahmoud A. El Hassab, et al.. (2023). Morphologic design of nanogold carriers for a carbonic anhydrase inhibitor: Effect on ocular retention and intraocular pressure. International Journal of Pharmaceutics. 642. 123161–123161. 4 indexed citations
13.
Mughal, Ehsan Ullah, Eslam B. Elkaeed, Zaman Ashraf, et al.. (2022). Synthesis and biological evaluation of substituted aurone derivatives as potential tyrosinase inhibitors: in vitro, kinetic, QSAR, docking and drug-likeness studies. Journal of Biomolecular Structure and Dynamics. 41(17). 8307–8322. 23 indexed citations
14.
Abdallah, Abdallah E., Sally I. Eissa, Eslam B. Elkaeed, et al.. (2022). Synthesis, biological evaluation, and molecular docking of new series of antitumor and apoptosis inducers designed as VEGFR-2 inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry. 37(1). 573–591. 46 indexed citations
15.
Javed, Mohsin, Muhammad Azam Qamar, Shahid Iqbal, et al.. (2022). Synergistic Influences of Doping Techniques and Well‐Defined Heterointerface Formation to Improve the Photocatalytic Ability of the S‐ZnO/GO Nanocomposite. ChemistrySelect. 7(29). 17 indexed citations
16.
Elkaeed, Eslam B., Ibrahim H. Eissa, Hazem Elkady, et al.. (2022). A Multistage In Silico Study of Natural Potential Inhibitors Targeting SARS-CoV-2 Main Protease. International Journal of Molecular Sciences. 23(15). 8407–8407. 44 indexed citations
17.
Elwan, Alaa, Abdallah E. Abdallah, Hazem A. Mahdy, et al.. (2022). Modified Benzoxazole-Based VEGFR-2 Inhibitors and Apoptosis Inducers: Design, Synthesis, and Anti-Proliferative Evaluation. Molecules. 27(15). 5047–5047. 51 indexed citations
18.
Фазылов, С. Д., et al.. (2022). Combined Computational and Experimental Studies of Anabasine Encapsulation by Beta-Cyclodextrin. Plants. 11(17). 2283–2283. 9 indexed citations
19.
Elkaeed, Eslam B., Fadia S. Youssef, Ibrahim H. Eissa, et al.. (2022). Multi-Step In Silico Discovery of Natural Drugs against COVID-19 Targeting Main Protease. International Journal of Molecular Sciences. 23(13). 6912–6912. 52 indexed citations
20.
Elkaeed, Eslam B., et al.. (2022). Molecular Docking and Dynamic Simulation Revealed the Potential Inhibitory Activity of Opioid Compounds Targeting the Main Protease of SARS‐CoV‐2. BioMed Research International. 2022(1). 1672031–1672031. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kanchugarakoppal S. Rangappa Breakdown of academic impact, for papers by Mohammad Shahar Yar Breakdown of academic impact, for papers by Yousry A. Ammar Breakdown of academic impact, for papers by Ähmed Kamal Breakdown of academic impact, for papers by Mohamed A. Al‐Omar Breakdown of academic impact, for papers by Harun Patel Breakdown of academic impact, for papers by Wei Lü Breakdown of academic impact, for papers by Abdulrahman A. Almehizia Breakdown of academic impact, for papers by Raj Kumar Breakdown of academic impact, for papers by Subhash Padhyé
Rankless by CCL
2026